Harvard Business Review

JUNE 16, 2016

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The private sector spends three times that , mostly on translational research intended to transform basic discoveries into new products. There is a wide chasm that separates an initial discovery and a viable product idea.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

SEPTEMBER 14, 2011

In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Reliance MediaWorks.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

MARCH 5, 2012

A major reason for the decline in manufacturing employment in recent decades is the huge increases in the productivity of American factories. With those productivity gains likely to continue (a good thing), it is hard to imagine how manufacturing could ever return to its glory days, when it employed about a quarter of the U.S.

Health Care 9

Health Care Biotechnology Industry Policies 9

Harvard Business Review

SEPTEMBER 11, 2014

That’s because there are two primary types of uncertainty — demand uncertainty (will customers buy your product?) In fact, among the top 10 companies of the Forbes Most Innovative Companies list (since 2011 when we started the list), more than 80% of the most innovative companies compete in industries in the top right quadrant.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22